Praluent Alirocumab — Blue Cross Blue Shield Of New Mexico
5 indications indexed for this drug.
- Clinical Atherosclerotic Cardiovascular Disease AscvdView coverage criteria
- Elevated 10 Year Ascvd Risk With Ldl C Elevation While On StView coverage criteria
- Heterozygous Familial Hypercholesterolemia HefhView coverage criteria
- Homozygous Familial Hypercholesterolemia HofhView coverage criteria
- Primary HyperlipidemiaView coverage criteria